People with Alzheimer’s disease (AD) seem especially prone to seizures. Now, a Finnish study reports that antiepileptic drugs (AEDs) may increase the risk of stroke in people with AD.

The study enrolled 5,617 AD patients taking AEDs and the same number of matched control AD patients. Compared with controls, AD patients on AEDs were 37 per cent more likely to experience a stroke.

AED use was associated with a 34 and 44 per cent increase in the risk of ischaemic and haemorrhagic strokes. Stroke risk more than doubled during the first 90 days (adjusted hazard ratio 2.36) of AED use. The risk associated with older drugs (e.g. carbamazepine, phenobarbital, phenytoin and primidone) did not differ to that associated with newer AEDs.

“The pathological changes in Alzheimer’s disease may increase susceptibility to the adverse events of AEDs,” the authors concluded. “Careful clinical consideration is needed before prescribing them to a person with Alzheimer’s.”

Originally Published by Pharmacy Magazine


Alliance Healthcare celebrates 80th anniversary

Pharmaceutical wholesaler Alliance Healthcare has marked its 80-year anniversary with a series of events and activities

Calorie focus for NHS DPP

The NHS will for the first time pilot at scale the very low calorie diets that have been shown to put type 2 diabetes in...

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Training Matters's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.